Skip to content
Search

Latest Stories

Leverage pharmacy skill mix to improve medicines adherence - report suggests

Public Policy Projects calls for better use of community pharmacy skill mix to improve medicines adherence
Non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed. (gettyimages)

The report also suggested expanding the community pharmacy contractual framework to enable community pharmacy to deliver medicines reviews

Pharmacy technicians and assistants should be enabled to talk to patients about their medications to improve medicines adherence, a new report has recommended.

The report, How medicines optimisation contributes to population health, published recently by policy institute Public Policy Projects, highlighted that non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed.


“There is an untapped opportunity to leverage community pharmacy, which is often patients’ most frequent point of contact with the NHS, to improve medicines adherence,” the report stated.

It has urged the NHS England and the Department of Health and Social Care (DHSC) to consider “how to better utilise the skill mix across the whole pharmacy team” as part of future workforce reform to improve medicines adherence.

For example, it suggested enabling pharmacy technicians and assistants to counsel patients on their medications.

“This would more effectively distribute workload, freeing up time for pharmacists to take a more strategic role in population health management,” the report noted.

With discussions ongoing about the new Community Pharmacy Contractual Framework (CPCF) for 2024/25 and 2025/26 between Community Pharmacy England (CPE), NHS England, and DHSC, the report also recommended expanding the contract to allow community pharmacy to deliver medicines reviews.

“By capitalising on community pharmacy’s frequent interactions and strong relationships with local communities, enabling the sector to conduct medicines reviews would reduce pressure across systems and allow patients more flexible and convenient access to care,” it said.

Furthermore, the report argued that the current workforce model is not sufficient to support the community pharmacy sector to deliver contracted services and enable additional service delivery.

It suggested mandating a minimum of two pharmacists in community pharmacies – one to support medicines supply and the other for the delivery of clinical services – as part of future workforce planning.

The report is based on insights from a roundtable discussion with pharmacy experts, chaired by Minesh Parbat, chief pharmacist at NHS Shropshire, Telford and Wrekin ICB.

Attendees included ICB chief pharmacists, acute trust chief pharmacists, pharmacy policy experts, NPA board members, directors of pharmacy integration, and pharmacy technicians.

Parbat said: “The findings in this report underscore pharmacy’s ability to go further to improve health outcomes through medicines optimisation and the potential to deliver pharmaceutical interventions to target health inequalities more broadly.”

“In particular, by leveraging the frequent patient contact seen by community pharmacies, we can go further to support the improvement of medicines adherence, which in turn supports the NHS to gain the maximum value out of the medicines it purchases.”

He also emphasised the need to integrate pharmacies into broader healthcare and data systems to ensure patients receive timely and effective care, which will also benefit the wider NHS.

Other key recommendations

Here are some other recommendations from Public Policy Projects –

  • NICE should investigate the feasibility of prioritising patient populations depending on clinical need for newly approved medicines.
  • NHS England and DHSC should consider expanding the role of community pharmacies in delivering all adult vaccinations to address declining uptake rates.
  • As Integrated Care Boards (ICBs) move toward full delegated commissioning, decision-makers should consider commissioning services in community pharmacy.
  • NHS England should create a defined role for community pharmacy as part of Enhanced Access service delivery.
  • ICBs should ensure pharmacy teams adopt a population health management approach to Structured Medicines Reviews and other pharmaceutical services, supported by the requisite digital capability.

However, the report underscored that persistent challenges facing the sector must be addressed for pharmacies to take a more central role in population health management.

 

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less